Value through Innovation27 July 2016

Clinical Study Results

  • BIBT 1011 - Healthy
    Clinical Study Number 1193.1
    Study Indication Healthy
    Product BIBT 1011
    Generic Name BIBT 1011
    Lab Code
    Clinical Phase I
    Study Title

    Safety, pharmacodynamics, and pharmacokinetics after single oral administration of 1, 5, 10, 30,100,200 and 400 mg BIBT 1011 BS as drinking solution in healthy subjects. An open, placebo­ controlled, randomised study, double blind at each dose level.

    Study Document Trial synopsis 1193.1 english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.